Sands Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,732
Closed -$896K 77
2024
Q1
$896K Buy
12,732
+178
+1% +$12.7K ﹤0.01% 65
2023
Q4
$969K Buy
12,554
+3,024
+32% +$199K ﹤0.01% 63
2023
Q3
$649K Buy
9,530
+1,964
+26% +$155K ﹤0.01% 64
2023
Q2
$618K Sell
7,566
-739,788
-99% -$59.5M ﹤0.01% 66
2023
Q1
$55.4M Buy
747,354
+10,881
+1% +$839K 0.18% 56
2022
Q4
$61M Buy
736,473
+13,513
+2% +$1.07M 0.23% 56
2022
Q3
$51.3M Buy
722,960
+85,972
+13% +$7.43M 0.19% 59
2022
Q2
$55.2M Sell
636,988
-26,644
-4% -$2.5M 0.19% 59
2022
Q1
$71.8M Buy
663,632
+274,752
+71% +$28.3M 0.17% 58
2021
Q4
$50.3M Sell
388,880
-7,732
-2% -$948K 0.09% 61
2021
Q3
$48M Buy
396,612
+4,868
+1% +$592K 0.08% 62
2021
Q2
$44.1M Buy
391,744
+44,204
+13% +$4.65M 0.07% 68
2021
Q1
$33.2M Buy
+347,540
New +$31.7M 0.06% 66

Other funds holding TECH

Sands Capital Management's TECH Position: Q2 2024 in Review

Sands Capital Management sold out of Bio-Techne (TECH) in Q2 2024, closing a stake of 12,732 shares — an estimated $896K sold.

Sands Capital Management first reported a position in TECH in Q1 2021 and held it in 13 quarters. The position peaked at $71.8M in Q1 2022. 572 funds tracked by Wall St. Rank hold TECH as of Q2 2024.

  • Sands Capital Management reported no remaining Bio-Techne position as of Q2 2024 after selling out during the quarter.
  • Sands Capital Management sold 12,732 Bio-Techne shares in Q2 2024, an estimated $896K.
  • Sands Capital Management first reported a position in Bio-Techne in Q1 2021 and held it in 13 quarters.
  • Sands Capital Management's Bio-Techne position peaked at $71.8M in Q1 2022.
  • 572 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2024.

Based on Sands Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.